General Federal Contracts — July 23, 2026

Booz Allen Hamilton received a $1.07 billion defense contract from GSA, the largest award in this digest at 83% of total value, signaling strong demand for defense consulting services.

Air Products and Chemicals secured a $120.3 million firm-fixed-price delivery order from NASA for helium support at Kennedy Space Center, with a total potential value of $172 million through 2025, providing stable recurring revenue.

IAVI Inc. secured a $95.6 million firm-fixed-price contract from HHS/BARDA for Marburg and Sudan ebolavirus vaccine development, but the fixed-price R&D structure transfers cost overrun risk to the nonprofit, which has limited financial buffers.

IAVI's $95.6M fixed-price R&D contract from HHS carries high execution risk due to cost overrun exposure for a nonprofit with limited financial buffers.

Booz Allen Hamilton's $1.07B contract represents 83% of total digest value, creating single-contract concentration risk for investors tracking government services exposure.

Booz Allen Hamilton's $1.07B defense contract from GSA signals robust demand for defense consulting, creating opportunities for peers like Leidos, CACI, and SAIC to capture similar awards.

Air Products' $120M NASA helium contract through 2025 indicates stable investment in space launch infrastructure, benefiting industrial gas suppliers and space sector ETFs.

Booz Allen Hamilton's $1.07B sole-source defense contract from GSA underscores the government's reliance on large defense consulting firms for mission-critical support.

Air Products' $120M NASA helium contract for Kennedy Space Center highlights sustained government investment in space launch infrastructure, benefiting industrial gas suppliers.

{"entity"=>"Booz Allen Hamilton", "reason"=>"The $1.07B defense contract from GSA is the largest award in this digest and signals strong competitive moat, but concentration risk warrants monitoring.", "trigger"=>"Re-compete announcement or option exercise dates for this contract"}

{"entity"=>"Air Products and Chemicals", "reason"=>"The $120M NASA helium contract provides multi-year revenue visibility through 2025, with potential upside from option exercises.", "trigger"=>"Option exercise announcements or new delivery orders under this contract"}

{"entity"=>"IAVI Inc.", "reason"=>"The $95.6M HHS contract carries high execution risk due to fixed-price R&D structure, but successful milestones could unlock additional funding.", "trigger"=>"Milestone progress reports or BARDA option exercises"}